Q1'19 digital health investments slow, but IPOs brewing

The latest data from Rock Health shows M&A was also down, with 21 acquisitions compared to quarterly averages of 31 deals in recent years.

By Maria Rachal • April 2, 2019

Smith & Nephew picks up pressure injury prevention device

The medtech said Wednesday it completed its acquisition of Leaf Healthcare, following a two-year partnership with the wireless patient monitoring system startup.

By Maria Rachal • Updated April 17, 2019

Private equity sees ripe opportunity in healthcare this year

Potential targets include orthopaedics, gastroenterology and urology practices and mental health and addiction services, analysts say.

By Samantha Liss • March 25, 2019

Stryker to spend up to $220M on rotator cuff tear tech

The Kalamazoo, Michigan-based medtech announced it has closed a deal with Israeli startup OrthoSpace, which formerly drew investment from Johnson & Johnson and Smith & Nephew.

By Maria Rachal • March 14, 2019

Smith & Nephew buys skin substitute maker for $660M

The company announced Wednesday it closed the acquisition of Osiris Therapeutics. 

By Susan Kelly • Updated April 17, 2019

Hill-Rom strikes $180M Voalte takeover to boost connected care unit

The acquisition will give the hospital equipment maker a communications system to complement its portfolio of smart devices.

By Nick Paul Taylor • March 13, 2019

Edwards deepens structural heart position with new investments

Deals with Corvia Medical and Mitralign could bolster the valve specialist's structural heart treatment abilities, where the company said it intends to remain focused.

By Susan Kelly • March 12, 2019

Philips nabs Carestream unit to boost informatics business

The healthcare electronics company hopes the takeover will strengthen its informatics presence outside of North America.

By Nick Paul Taylor • March 8, 2019

Accenture to buy Irish manufacturing services firm ESP

ESP will join Accenture's digitally-focused unit and bring along its clients, which include Stryker and Boston Scientific.

By Kristin Jensen • March 7, 2019

Oral arguments in ACLA v. Azar appeal set for April 23

In a brief, HHS argued the American Clinical Laboratory Association does not have standing to bring a lawsuit over implementation of the Protecting Access to Medicare Act.

By David Lim • March 7, 2019

Pharma strikes $220M deal for pain device player Myoscience

New Jersey-based Pacira is moving into the device sector to build a portfolio of pain products capable of reducing the need for opioids.

By Nick Paul Taylor • March 6, 2019

Stryker buys Arrinex to expand ENT portfolio

The takeover gives Stryker's growing ENT business a chronic rhinitis device.

By Nick Paul Taylor • Feb. 26, 2019

GE selling off biopharma business in $21.4B deal

Danaher's massive buy bolsters its life sciences unit. GE, meanwhile, plans to strengthen its balance sheet with the cash infusion and is reportedly pausing IPO plans for GE Healthcare.

By Andrew Dunn • Feb. 25, 2019

Boston Scientific-BTG deal faces FTC holdup

The embolization beads businesses are at the heart of U.S. anti-trust regulators' concerns.

By Maria Rachal • Feb. 15, 2019

HIMSS19: Digital health 'at peak investment cycle,' expert says

Last year's record level of investment into United States digital health companies came despite a lull in initial public offerings.

By David Lim • Feb. 14, 2019

Boston Scientific targets structural heart, international market growth in 2019

A near-constant stream of acquisitions defined the device giant's 2018. Now, it's looking ahead to product launches in the U.S., Europe and Japan.

By Maria Rachal • Feb. 6, 2019

Zimmer Biomet narrowly beats Q4 expectations, looks to Rosa knee soft launch

RBC Capital Markets analysts predicted the company's second half of 2019 is primed for faster growth once Rosa and other new knee product launches kick in.

By David Lim • Feb. 1, 2019

Many health startups, like Theranos, lack peer-reviewed data to back claims

Of 18 current healthcare "unicorns," 10 had no highly cited published medical papers and three had no published papers at all, according to Stanford researchers.

By Meg Bryant • Jan. 31, 2019

Medtronic buys Epix to boost cardiac ablation unit

Terms for the acquisition were not disclosed, but the device giant said the company is pre-revenue and the deal will be dilutive.

By David Lim • Jan. 25, 2019

As shutdown stalls IPOs, companies mull creative paths to market

Biotechs in the process of going public are considering legal workarounds to bypass a hamstrung SEC, but the Nasdaq appears to be proceeding warily.

By Andrew Dunn • Jan. 18, 2019

Abbott inks Cephea buyout to boost mitral valve pipeline

The takeover gives Abbott another valve replacement device to rival those owned by Edwards and Medtronic.

By Nick Paul Taylor • Jan. 17, 2019

LabCorp and Quest prepare for year of M&A as price cuts hit small labs

The laboratory testing giants expect reimbursement reductions to wipe out profits at smaller rivals, triggering a period of heavy consolidation.

By Nick Paul Taylor • Jan. 9, 2019

Wright Medical posts $9.5M in Cartiva revenue, beating expectations

The device maker's acquisition of Cartiva and its big toe arthritis implant boosted results. 

By David Lim • Jan. 7, 2019

Boston Scientific strikes $325M Millipede mitral valve repair buyout

The takeover gives Boston Scientific a foothold in a market predicted to grow to $1 billion by 2021.

By Nick Paul Taylor • Jan. 3, 2019

Regulatory makeovers and international game changers: MedTech Dive's top stories of 2018

Hard looks at cybersecurity and digital health's hot streak also left their mark on the year.

By Maria Rachal • Dec. 22, 2018